BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31169211)

  • 1. Improvement of dose distribution in ocular brachytherapy with
    Zabihzadeh M; Rezaee H; Hosseini SM; Feghhi M; Danyaei A; Hoseini-Ghahfarokhi M
    J Cancer Res Ther; 2019; 15(3):504-511. PubMed ID: 31169211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
    Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
    J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by
    Rezaei H; Zabihzadeh M; Ghorbani M; Goli Ahmadabad F; Mostaghimi H
    Australas Phys Eng Sci Med; 2017 Sep; 40(3):545-553. PubMed ID: 28509080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
    Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
    J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric and radiobiologic comparison of
    Gorovets D; Gagne NL; Melhus CS
    Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel low-kVp beamlet system for choroidal melanoma.
    Esquivel C; Fuller CD; Waggener RG; Wong A; Meltz M; Blough M; Eng TY; Thomas CR
    Radiat Oncol; 2006 Sep; 1():36. PubMed ID: 16965624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
    Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
    Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
    Lee YC; Lin SC; Kim Y
    Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo dosimetry modeling of focused kV x-ray radiotherapy of eye diseases with potential nanoparticle dose enhancement.
    Yan H; Ma X; Sun W; Mendez S; Stryker S; Starr-Baier S; Delliturri G; Zhu D; Nath R; Chen Z; Roberts K; MacDonald CA; Liu W
    Med Phys; 2018 Oct; 45(10):4720-4733. PubMed ID: 30133705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
    Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 16 mm OSU-Nag and COMS eye plaques.
    Zhang H; Davidorf F; Qi Y
    J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A detailed Monte Carlo evaluation of
    Gray T; Bassiri N; David S; Patel DY; Stathakis S; Kirby N; Mayer KM
    Phys Med Biol; 2020 Jul; 65(13):135007. PubMed ID: 32434159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.